Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.

CONCLUSIONS: The use of a LMWH VTE prophylaxis was not associated with a reduction in the incidence of in-hospital VTE as compared to UFH, but was associated with significant reduction in clinically important bleeding events and incidence of HIT in critically ill patients with cancer. This article is protected by copyright. All rights reserved.
PMID: 30347498 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - October 22, 2018 Category: Hematology Authors: Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH Tags: J Thromb Haemost Source Type: research